Phreesia (NYSE:PHR) Stock Price Down 5.9% – Should You Sell?

Phreesia, Inc. (NYSE:PHR) fell 5.9% during mid-day trading on Tuesday . The stock traded as low as $10.28 and last traded at $10.30. 119,152 shares were traded during trading, a decline of 92% from the average daily volume of 1,485,985 shares. The stock had previously closed at $10.94.

Analysts Set New Price Targets

Several research firms recently commented on PHR. Royal Bank Of Canada restated an “outperform” rating and issued a $19.00 target price on shares of Phreesia in a research report on Thursday, September 3rd. Wells Fargo & Company boosted their price target on Phreesia from $9.00 to $10.00 and gave the stock an “equal weight” rating in a research report on Thursday, September 3rd. Needham & Company LLC reissued a “buy” rating and issued a $14.00 price target on shares of Phreesia in a research note on Monday, August 31st. Raymond James Financial lowered Phreesia from an “outperform” rating to a “market perform” rating in a report on Tuesday. Finally, Piper Sandler cut shares of Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 price objective on the stock. in a research note on Thursday, May 28th. Eight research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Phreesia currently has an average rating of “Hold” and an average price target of $14.00.

Phreesia Trading Up 1.3%

The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.76 and a current ratio of 1.76. The business has a 50 day simple moving average of $11.26 and a 200-day simple moving average of $10.43. The stock has a market capitalization of $642.55 million, a P/E ratio of 60.90 and a beta of 0.86.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). Phreesia had a return on equity of 5.22% and a net margin of 2.06%.The firm had revenue of $129.46 million for the quarter, compared to analyst estimates of $129.06 million. During the same period in the previous year, the firm earned $0.01 earnings per share. Phreesia’s revenue was up 10.4% on a year-over-year basis. On average, analysts predict that Phreesia, Inc. will post 0.38 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of PHR. Pale Fire Capital SE lifted its holdings in shares of Phreesia by 3.2% during the second quarter. Pale Fire Capital SE now owns 8,924,329 shares of the company’s stock valued at $91,831,000 after purchasing an additional 275,000 shares during the last quarter. BlackRock Inc. purchased a new stake in Phreesia during the second quarter valued at about $72,234,000. Vanguard Group Inc. boosted its holdings in shares of Phreesia by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 5,744,326 shares of the company’s stock worth $97,194,000 after buying an additional 39,540 shares during the period. Granahan Investment Management LLC boosted its holdings in shares of Phreesia by 73.8% in the fourth quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock worth $40,601,000 after buying an additional 1,018,987 shares during the period. Finally, Franklin Resources Inc. increased its position in shares of Phreesia by 28.8% in the fourth quarter. Franklin Resources Inc. now owns 2,000,082 shares of the company’s stock worth $33,841,000 after acquiring an additional 446,890 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.